Anton D Michel Selected Research

GSK726701A

1/2018

Discovery of {4-[4,9-bis(ethyloxy)-1-oxo-1,3-dihydro-2H-benzo[f]isoindol-2-yl]-2-fluorophenyl}acetic acid (GSK726701A), a novel EP4 receptor partial agonist for the treatment of pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anton D Michel Research Topics

Disease

4	Pain (Aches) 01/2018 - 01/2007
1	Chronic Pain 04/2012
1	Migraine Disorders (Migraine) 04/2012
1	Nervous System Diseases (Neurological Disorders) 04/2012
1	Neuralgia (Stump Neuralgia) 04/2005
1	Hypersensitivity (Allergy) 04/2005
1	Hypoxia (Hypoxemia) 03/2004

Drug/Important Bio-Agent (IBA)

1	LigandsIBA 01/2018
1	GSK726701AIBA 01/2018
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2018
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 09/2010
1	AmidesIBA 09/2010
1	Freund's AdjuvantIBA 08/2010
1	ProstaglandinsIBA 01/2007
1	6- (2- (5- chloro- 2- (((2,4- difluorophenyl)methyl)oxy)phenyl)- 1- cyclopenten- 1- yl)- 2- pyridinecarboxylic acidIBA 01/2007
1	AcidsIBA 01/2007
1	Purinergic P2X7 ReceptorsIBA 04/2005
1	acadesineIBA 03/2004

Therapy/Procedure

1	Therapeutics 04/2012
1	Ligation 04/2005